Literature DB >> 27339385

The Necrosome in Acute Kidney Injury.

Yanfang Xu1, Jiahuai Han2.   

Abstract

Cell death and inflammation in the proximal tubules are the hallmarks of acute kidney injury (AKI), but the underlying mechanism has not been fully elucidated. Recent evidence has shown that necroptosis, a type of programmed necrosis, plays an important role in AKI. The necrosis-inducing signaling complex is called the necrosome, which contains receptor-interacting protein 1, receptor-interacting protein 3, and mixed lineage kinase domain-like protein. Studies have found that inhibition of the core components of the necroptotic pathway by gene knockout, RNA interference, or a chemical inhibitor diminished proximal tubule damage, showing that necroptosis is a major contributor to AKI. This review focuses on the functional roles of the necrosome in regulating renal tubular cell necroptosis, and the physiological and pathologic roles of necrosome in AKI.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Necrosome; acute kidney injury; necroptosis

Mesh:

Substances:

Year:  2016        PMID: 27339385     DOI: 10.1016/j.semnephrol.2016.03.007

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  9 in total

Review 1.  Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways.

Authors:  Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2019-02-28       Impact factor: 3.714

2.  GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy.

Authors:  Yinshuang Li; Ying Yuan; Zhong-Xing Huang; Hui Chen; Ruilong Lan; Zeng Wang; Kunmei Lai; Hong Chen; Zhimin Chen; Zhenhuan Zou; Hua-Bin Ma; Hui-Yao Lan; Tak W Mak; Yanfang Xu
Journal:  Cell Death Differ       Date:  2021-03-04       Impact factor: 12.067

3.  Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine kinase 1 and inhibiting necroptosis.

Authors:  Xiaodong Yuan; Dawei Li; Xiaosong Chen; Conghui Han; Longmei Xu; Tao Huang; Zhen Dong; Ming Zhang
Journal:  Cell Death Dis       Date:  2017-12-11       Impact factor: 8.469

4.  The Impact of Versatile Macrophage Functions on Acute Kidney Injury and Its Outcomes.

Authors:  Jea-Hyun Baek
Journal:  Front Physiol       Date:  2019-08-06       Impact factor: 4.566

Review 5.  Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion.

Authors:  Lian-Cheng Deng; Tahereh Alinejad; Saverio Bellusci; Jin-San Zhang
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

Review 6.  Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review.

Authors:  Jung Yoon Jang; Eunok Im; Yung Hyun Choi; Nam Deuk Kim
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

7.  Remote ischemic preconditioning causes transient cell cycle arrest and renal protection by a NF-κB-dependent Sema5B pathway.

Authors:  Jan Rossaint; Melanie Meersch; Katharina Thomas; Sina Mersmann; Martin Lehmann; Jennifer Skupski; Tobias Tekath; Peter Rosenberger; John A Kellum; Hermann Pavenstädt; Alexander Zarbock
Journal:  JCI Insight       Date:  2022-07-22

8.  Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.

Authors:  Shifeng Zhao; Xueqiao Wang; Xiaoqing Zheng; Xiu Liang; Zhigang Wang; Juanlian Zhang; Xudong Zhao; Shougang Zhuang; Qiuhui Pan; Fenyong Sun; Wenjun Shang; Jonathan Barasch; Andong Qiu
Journal:  Free Radic Biol Med       Date:  2021-07-21       Impact factor: 8.101

9.  Activation of aryl hydrocarbon receptor by 6-formylindolo[3,2-b]carbazole alleviated acute kidney injury by repressing inflammation and apoptosis.

Authors:  Sibei Tao; Fan Guo; Qian Ren; Jing Liu; Tiantian Wei; Lingzhi Li; Liang Ma; Ping Fu
Journal:  J Cell Mol Med       Date:  2020-12-06       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.